Literature DB >> 1634322

Subacute sclerosing panencephalitis in The Netherlands--1976-1990.

M F Beersma1, J M Galama, H A Van Druten, W O Renier, C J Lucas, J G Kapsenberg.   

Abstract

Since 1976, when general immunization against measles was introduced in the Netherlands, all new cases of subacute sclerosing panencephalitis (SSPE) were registered and detailed data about immunization, epidemiology and disease progression were collected on them. Up to 1991, 99 new patients have been registered of which 81 were born in this country and 18 elsewhere. From 1981 onwards, the incidence of SSPE among those born in the Netherlands decreased gradually from 13 cases per year to one case per year. This decrease is attributed to the large scale of immunization against measles. Three SSPE patients had been immunized against measles, all of them without a history of clinical measles. Epidemiology and risk factors of SSPE did not differ from those reported in other countries. An exceptional cluster of four patients in one town, who had measles in the same year, is reported. Progression of SSPE appeared to be age related. A total of 28 patients was treated with Inosiplex; no significant effect on survival in stage 3 of the disease was found.

Entities:  

Mesh:

Year:  1992        PMID: 1634322     DOI: 10.1093/ije/21.3.583

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  3 in total

1.  The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.

Authors:  C Miller; N Andrews; M Rush; H Munro; L Jin; E Miller
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

2.  Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.

Authors:  Laurens Manning; Moses Laman; Henry Edoni; Ivo Mueller; Harin A Karunajeewa; David Smith; Ilomo Hwaiwhanje; Peter M Siba; Timothy M E Davis
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04

Review 3.  Neurological Complications of Measles (Rubeola).

Authors:  Marc C Patterson
Journal:  Curr Neurol Neurosci Rep       Date:  2020-02-07       Impact factor: 6.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.